Compare company and executive activity with congressional disclosures. Coinciding events do not establish coordination or wrongdoing.
Loading SEC filings and reported buybacks…
Open-market or private purchases of non-derivative securities reported by officers and directors (code P). Grants, option exercises, and sales are excluded. These are personal transactions, not company buybacks.
Head of Pharm Ops and Tech · Common Stock
Transaction: 2026-02-12
Filed: 2026-02-17
The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.
Free includes up to 3 qualifying purchases from the latest 20 ownership filings and the latest reported buyback period. Plus unlocks older available filing pages and reported buyback history.
Compare plansReported cash payments to repurchase common stock, in US dollars. Periods can overlap and include year-to-date totals; do not add these rows together. These are reported payments, not announcement amounts or daily trades.
| Reporting period | Cash paid (USD) | Filed | Source |
|---|---|---|---|
| 2024-01-01 – 2024-12-31 | $0.00 | 2025-02-12 | 10-K ↗ |
Latest available standardized authorization fact: 2016-09-30. Filed 2017-02-02.
This may be an old or cumulative program amount. It is not a new announcement, remaining capacity, or a commitment to purchase shares.
Read the program terms in the filing ↗